ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Tin Fluorides

Also written as “0.454% Stannous Fluoride Dentifrice”, “Stannous fluoride toothpaste” and “Stannous Fluoride”.

Its studies are mostly in Gingivitis · Dentin Sensitivity · Dental Plaque · Diabetes Mellitus, Type 2 · Halitosis, led by 5 companies.

Drug pageTin Fluorides: every studyMany companies study it; this page follows only the 47 they lead. All 44 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Feb 6, 201547 company-led studies, 4 open or runningNext primary completion: Sep 2027 (phase 4)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Colgate Palmoliveits history only182 open or runningphase 4since Feb 6, 2015Sep 26, 2008Sep 2027phase 4 · NCT07807397
Procter and Gambleits history only142 open or runningphase 4since Aug 28, 2025Feb 28, 2012none ahead
GlaxoSmithKlineits history only80 open or runningphase 3since May 3, 2012May 3, 2012none ahead
HALEON40 open or runningno phasesince Nov 16, 2023Nov 16, 2023none ahead
Church & Dwightits history only30 open or runningno phasesince Feb 12, 2026Feb 12, 2026none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of HALEON only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Nov 16, 2023First study: no phase study in GingivitisFirst studyNCT06143670 · 159 enrolled · United States
  2. Mar 20, 2024No phase study in Dentin SensitivityNCT06359028 · 111 enrolled · United States
  3. Apr 3, 2024No phase study in Dentin SensitivityNCT06354270 · 115 enrolled · United States
  4. Oct 24, 2024No phase study in Dental PlaqueNCT06660069 · 199 enrolled · United States

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 HALEON leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06660069Dental Plaque · United States–CompletedMar 11, 2025199
NCT06354270Dentin Sensitivity · United States–CompletedJun 23, 2024115
NCT06359028Dentin Sensitivity · United States–CompletedJun 20, 2024111
NCT06143670Gingivitis · United States–CompletedMar 12, 2024159

How it is read

Names in the registry

  • “0.454% Stannous Fluoride Dentifrice”, 8 entries
  • “Stannous fluoride toothpaste”, 7 entries
  • “Stannous Fluoride”, 6 entries
  • “stannous fluoride toothpaste”, 5 entries
  • “Stannous Fluoride Toothpaste (SnF)”, 5 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.